Drug Trial Radar · NCT02684006
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Last checked: Nov 20, 2026Latest source record: Jul 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
886
Actual
Start
Mar 23, 2016
Primary completion
Aug 31, 2023
Study completion Jun 26, 2024
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Feb 17, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 3 randomized trial evaluating the anti-tumor activity and safety of avelumab in combination with axitinib and of sunitinib monotherapy, administered as first-line treatment, in patients with advanced renal cell carcinoma
Conditions
- Renal Cell Cancer
Interventions
Avelumab (MSB0010718C)Drug
IV treatment Avelumab administered at 10 mg/kg IV every two weeks
Axitinib (AG-013736)Drug
Oral treatment Axitinib given 5 mg PO BID
SunitinibDrug
Oral treatment Sunitinib given at 50 mg PO QD on schedule 4/2
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression Free Survival (PFS) as Assessed by Blinded Independent Central Review (BICR) in Programmed Death-Ligand 1 (PD-L1) Positive ParticipantsTime frame: From date of randomization to the first documentation of PD or death due to any cause or censoring date, whichever occurred first (maximum up to approximately 26 months)
- Overall Survival (OS) in PD-L1 Positive ParticipantsTime frame: From the date of randomization to the date of death due to any cause or censoring date, whichever occurred first (maximum up to approximately 89 months)
Locations
270 sites in 21 countries. Site status is shown where the registry gives one.
Southern Cancer Center
Daphne, Alabama
Southern Cancer Center
Mobile, Alabama
Southern Cancer Center
Mobile, Alabama
Tower Hematology Oncology Medical Group
Beverly Hills, California
City of Hope National Medical Center
Duarte, California
City of Hope
Duarte, California
Keck Hospital of USC
Los Angeles, California
Los Angeles General Medical Center
Los Angeles, California
USC IDS Pharmacy
Los Angeles, California
USC/Norris Comprehensive Cancer Center
Los Angeles, California
Cedars-Sinai Advanced Health Sciences Pavilion
Los Angeles, California
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute
Los Angeles, California
Cedars-Sinai
Los Angeles, California
Rocky Mountain Cancer Centers
Aurora, Colorado
University of Colorado Cancer Center Anschutz Cancer Pavilion
Aurora, Colorado
University of Colorado Hospital - Clinical Trials Office (CTO)
Aurora, Colorado
University of Colorado Hospital
Aurora, Colorado
Rocky Mountain Cancer Centers
Colorado Springs, Colorado
Georgetown University Medical Center
Washington D.C., District of Columbia
Moffitt Cancer Center and Research Institute
Tampa, Florida
Emory University Hospital
Atlanta, Georgia
Investigational Drug Service- Emory University
Atlanta, Georgia
The Emory Clinic
Atlanta, Georgia
Winship Cancer Institute, Emory University
Atlanta, Georgia
East Jefferson General Hospital
Metairie, Louisiana
East Jefferson Hematology-Oncology Metairie Physician Service Inc.
Metairie, Louisiana
New England Cancer Specialists
Kennebunk, Maine
New England Cancer Specialists
Scarborough, Maine
New England Cancer Specialists
Topsham, Maine
Oncology Investigational Drug Services- The Sidney Kimmel Cancer Center at Johns Hopkins Hospital
Baltimore, Maryland
Johns Hopkins Hospital
Baltimore, Maryland
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland
Massachusetts General Hospital (MGH)
Boston, Massachusetts
Massachusetts General Hospital Clinical Trials Pharmacy
Boston, Massachusetts
Brigham & Women's Hospital
Boston, Massachusetts
Beth Israel Deaconess Medical Center (BIDMC)
Boston, Massachusetts
Beth Israel Deaconess Medical Center Pharmacy - BIDMC
Boston, Massachusetts
Dana - Farber Cancer Institute
Boston, Massachusetts
Dana-Farber Cancer Institute
Boston, Massachusetts
Baystate Franklin Medical Center
Greenfield, Massachusetts
Showing 40 of 270 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.